NO20003694D0 - VLA-4 antagonists - Google Patents

VLA-4 antagonists

Info

Publication number
NO20003694D0
NO20003694D0 NO20003694A NO20003694A NO20003694D0 NO 20003694 D0 NO20003694 D0 NO 20003694D0 NO 20003694 A NO20003694 A NO 20003694A NO 20003694 A NO20003694 A NO 20003694A NO 20003694 D0 NO20003694 D0 NO 20003694D0
Authority
NO
Norway
Prior art keywords
vla
antagonists
Prior art date
Application number
NO20003694A
Other languages
Norwegian (no)
Other versions
NO20003694L (en
Inventor
Sompong Wattanasin
Peter Josef Von Matt
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20003694D0 publication Critical patent/NO20003694D0/en
Publication of NO20003694L publication Critical patent/NO20003694L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/42Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20003694A 1998-01-23 2000-07-19 VLA-4 antagonists NO20003694L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1233698A 1998-01-23 1998-01-23
US11072398P 1998-12-03 1998-12-03
PCT/EP1999/000384 WO1999037605A1 (en) 1998-01-23 1999-01-21 Vla-4 antagonists

Publications (2)

Publication Number Publication Date
NO20003694D0 true NO20003694D0 (en) 2000-07-19
NO20003694L NO20003694L (en) 2000-09-20

Family

ID=26683440

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003694A NO20003694L (en) 1998-01-23 2000-07-19 VLA-4 antagonists

Country Status (13)

Country Link
EP (1) EP1049665A1 (en)
JP (1) JP4564654B2 (en)
KR (1) KR20010034317A (en)
CN (1) CN1294576A (en)
AU (1) AU746174B2 (en)
BR (1) BR9907733A (en)
CA (1) CA2318639A1 (en)
EE (1) EE200000428A (en)
HU (1) HUP0100336A3 (en)
ID (1) ID26665A (en)
IL (1) IL137329A0 (en)
NO (1) NO20003694L (en)
WO (1) WO1999037605A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2623900A (en) * 1999-01-22 2000-08-07 American Home Products Corporation Compounds which inhibit leukocyte adhesion mediated by vla-4
JP4754693B2 (en) 1999-01-22 2011-08-24 エラン ファーマシューティカルズ,インコーポレイテッド Acyl derivatives for treating VLA-4 related disorders
US6436904B1 (en) 1999-01-25 2002-08-20 Elan Pharmaceuticals, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
CA2361162A1 (en) 1999-03-01 2000-09-08 Elan Pharmaceuticals, Inc. Alpha-aminoacetic acid derivatives useful as alpha 4 beta 7-receptor antagonists
JP2003516380A (en) * 1999-12-07 2003-05-13 ノバルティス アクチエンゲゼルシャフト VLA-4 integrin antagonist
CA2396087A1 (en) 1999-12-28 2001-07-19 Louis Stanley Chupak Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
DE10019755A1 (en) * 2000-04-20 2001-11-08 Bayer Ag New cyclic carboxylic acids are integrin antagonists, useful for treating inflammatory diseases, autoimmune and immune disorders, e.g. atherosclerosis, asthma and diabetes
GB2369357A (en) * 2000-10-09 2002-05-29 Bayer Ag Aliphatic, cyclic amino carboxylic acids as integrin antagonists
GB2367816A (en) 2000-10-09 2002-04-17 Bayer Ag Urea- and thiourea-containing derivatives of beta-amino acids
GB2377933A (en) 2001-07-06 2003-01-29 Bayer Ag Succinic acid derivatives useful as integrin antagonists
TW200307671A (en) 2002-05-24 2003-12-16 Elan Pharm Inc Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins
TWI281470B (en) 2002-05-24 2007-05-21 Elan Pharm Inc Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
TW200610754A (en) * 2004-06-14 2006-04-01 Daiichi Seiyaku Co Vla-4 inhibitor
GB0523576D0 (en) * 2005-11-18 2005-12-28 Theradeas Ltd Drug composition and its use in therapy
US20100150915A1 (en) 2007-02-20 2010-06-17 Stewart Edward J Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist
CA2721093A1 (en) 2008-04-11 2009-10-15 Merrimack Pharmaceuticals, Inc. Human serum albumin linkers and conjugates thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306840B1 (en) * 1995-01-23 2001-10-23 Biogen, Inc. Cell adhesion inhibitors
NZ505363A (en) * 1997-12-23 2005-02-25 Aventis Pharma Ltd Compounds containing substituted {2-[3-methoxy-4-(3-o-tolylureido)phenyl]acetylamino}- groups and pharmaceuticals thereof; useful as inhibitors of alpha4beta1 mediated cell division

Also Published As

Publication number Publication date
NO20003694L (en) 2000-09-20
AU746174B2 (en) 2002-04-18
WO1999037605A1 (en) 1999-07-29
EE200000428A (en) 2001-12-17
IL137329A0 (en) 2001-07-24
KR20010034317A (en) 2001-04-25
CA2318639A1 (en) 1999-07-29
CN1294576A (en) 2001-05-09
BR9907733A (en) 2000-10-17
JP2002501039A (en) 2002-01-15
JP4564654B2 (en) 2010-10-20
ID26665A (en) 2001-01-25
HUP0100336A3 (en) 2002-11-28
HUP0100336A2 (en) 2001-07-30
EP1049665A1 (en) 2000-11-08
AU2829299A (en) 1999-08-09

Similar Documents

Publication Publication Date Title
ID29066A (en) FENILGLISINA DOWN
ID27423A (en) KUINOLIN DOWN
ATE341990T1 (en) SIGMIDOSCOPE
ID23234A (en) BENZOSULFONA DOWN
ID27484A (en) ADENOSINA DOWN
NO990113D0 (en) Multihull-speed ° y
ID27547A (en) KUINOLIN DOWN
ID23287A (en) SUBSTITUTED TRISICLIC
NO994626D0 (en) Substituted benzamides
EE200000428A (en) VLA-4 antagonists
ATE262513T1 (en) BENZOYLPYRIDAZINE
ID23219A (en) SUBSTITUTED TRISICLIC
DE59901046D1 (en) Methylcyclotetradec-5-en-1-one
DE59807217D1 (en) NADELLAGER
DE1118098T1 (en) MEHRFACHFLUSSIGELEKTROSPRÜHSCHNITTSTELLE
ID28356A (en) DOWN TIAZOLA
FI980759A0 (en) Taetningskonstruktion Foer suglaodan i en sugvals
DE59808995D1 (en) endomicroscope
DE19842103B4 (en) Stanznietzuführung
DE59900612D1 (en) Dispersionsazofarbstoffmischungen
DE59912188D1 (en) SUBSTITUTED PHENYLURACILE
DE59912532D1 (en) SUBSTITUTED ACYLAMINOPHENYL-URACILE
DE59911610D1 (en) SUBSTITUTED BENZOYLCYCLOHEXANDIONE
DE29806492U1 (en) Construction machine
DE29819079U1 (en) Kombuchalyophilisate

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application